Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Medicine, Internal medicine, Biology, Lymphoblastic Leukemia, Oncology, and Cancer research.
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Tallforest: Multi-omic classifier for T-lineage acute lymphoblastic leukemia
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies <i>LMO2/STAG2</i> Rearrangements as Extremely High Risk
Clinical Actionability of the <i>NUDT15</i> *<i>4</i> (p.<scp>R139H</scp>) Allele and Its Association With Hispanic Ethnicity
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia
Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators
Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy
Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group
Association of unbalanced translocation der(1;7) with germline GATA2 mutations
Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia
Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16
Mixed‐phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial
The genetic basis and cell of origin of mixed phenotype acute leukaemia
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
Peripheral neuropathy in children and adolescents treated for cancer
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study
Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia